Skip to main content
. 2023 Nov 22;29(1):e51–e57. doi: 10.4317/medoral.26061

Table 4. Movement disorders and salivary flow related oral adverse reactions reported with antipsychotic drugs in the European Union pharmacovigilance database (EudraVigilance, 2012-2021).

graphic file with name medoral-29-e51-t004.jpg